{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:10:04Z","timestamp":1791609004097,"version":"4.3.4"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["CDF-2014-07-037"],"award-info":[{"award-number":["CDF-2014-07-037"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009360","name":"King\u2019s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1111\/bjd.16779","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T03:39:54Z","timestamp":1526614794000},"page":"582-589","source":"Crossref","is-referenced-by-count":73,"title":["Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines"],"prefix":"10.1093","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6183-6608","authenticated-orcid":false,"given":"L.","family":"Solman","sequence":"first","affiliation":[{"name":"Department of Paediatric Dermatology; Great Ormond Street Hospital for Children; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Glover","sequence":"additional","affiliation":[{"name":"Department of Paediatric Dermatology; Great Ormond Street Hospital for Children; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.","family":"Beattie","sequence":"additional","affiliation":[{"name":"Royal Hospital for Children; Glasgow U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Buckley","sequence":"additional","affiliation":[{"name":"Queen Alexandra Hospital; Portsmouth U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Clark","sequence":"additional","affiliation":[{"name":"Chapel Allerton Hospital; Leeds Teaching Hospitals NHS Trust; Leeds U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Gach","sequence":"additional","affiliation":[{"name":"Birmingham Children's Hospital; Birmingham U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Giardini","sequence":"additional","affiliation":[{"name":"Paediatric Cardiology Division; Great Ormond Street Hospital for Children; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Helbling","sequence":"additional","affiliation":[{"name":"Leicester Royal Infirmary; Leicester U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Hewitt","sequence":"additional","affiliation":[{"name":"Department of Paediatric Otolaryngology; Great Ormond Street Hospital for Children; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Laguda","sequence":"additional","affiliation":[{"name":"Chelsea and Westminster Hospital; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Langan","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Paediatric Dermatology; Great Ormond Street Hospital for Children; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Sheffield Teaching Hospitals; Sheffield U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Proudfoot","sequence":"additional","affiliation":[{"name":"The Royal Free London Hospital; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ravenscroft","sequence":"additional","affiliation":[{"name":"Nottingham Children's Hospital; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Shahidullah","sequence":"additional","affiliation":[{"name":"Derby Hospitals; Derby U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Shaw","sequence":"additional","affiliation":[{"name":"Department of Paediatric Dermatology; Great Ormond Street Hospital for Children; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.B.","family":"Syed","sequence":"additional","affiliation":[{"name":"Department of Paediatric Dermatology; Great Ormond Street Hospital for Children; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wells","sequence":"additional","affiliation":[{"name":"Nottingham Children's Hospital; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-6286","authenticated-orcid":false,"given":"C.","family":"Flohr","sequence":"additional","affiliation":[{"name":"Unit of Population-Based Dermatology Research and Department of Paediatric Dermatology; St John's Institute of Dermatology; Guy's and St Thomas\u2019 NHS Foundation Trust and King's College London; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"key":"10.1111\/bjd.16779-BIB0001|bjd16779-cit-0001","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/bjd.12804","article-title":"Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies","volume":"170","author":"Munden","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16779-BIB0002|bjd16779-cit-0002","doi-asserted-by":"crossref","first-page":"F85","DOI":"10.1136\/archdischild-2014-306197","article-title":"Incidence and treatment of infantile haemangioma in preterm infants","volume":"100","author":"Goelz","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1111\/bjd.16779-BIB0003|bjd16779-cit-0003","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1542\/peds.2007-2767","article-title":"Growth characteristics of infantile hemangiomas: implications for management","volume":"122","author":"Chang","year":"2008","journal-title":"Pediatrics"},{"key":"10.1111\/bjd.16779-BIB0004|bjd16779-cit-0004","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","article-title":"Infantile haemangioma","volume":"390","author":"Leaute-Labreze","year":"2017","journal-title":"Lancet"},{"key":"10.1111\/bjd.16779-BIB0005|bjd16779-cit-0005","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"Leaute-Labreze","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.16779-BIB0006|bjd16779-cit-0006","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1542\/peds.2010-0029","article-title":"A randomized controlled trial of propranolol for infantile hemangiomas","volume":"128","author":"Hogeling","year":"2011","journal-title":"Pediatrics"},{"key":"10.1111\/bjd.16779-BIB0007|bjd16779-cit-0007","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"Leaute-Labreze","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.16779-BIB0008|bjd16779-cit-0008","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/archdischild-2014-306514","article-title":"Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol","volume":"99","author":"Solman","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1111\/bjd.16779-BIB0009|bjd16779-cit-0009","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/bjd.14233","article-title":"Propranolol in the treatment of infantile haemangiomas: lessons from the European propranolol in the treatment of complicated haemangiomas (PITCH) taskforce survey","volume":"174","author":"Wedgeworth","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16779-BIB0010|bjd16779-cit-0010","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/bjd.13048","article-title":"Propranolol targets the contractility of infantile haemangioma-derived pericytes","volume":"171","author":"Lee","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16779-BIB0011|bjd16779-cit-0011","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/PRS.0b013e318267d3db","article-title":"Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells","volume":"130","author":"Wong","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/bjd.16779-BIB0012|bjd16779-cit-0012","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/pr.2013.231","article-title":"Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis","volume":"75","author":"Kum","year":"2014","journal-title":"Pediatr Res"},{"key":"10.1111\/bjd.16779-BIB0013|bjd16779-cit-0013","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/pde.12192","article-title":"Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy","volume":"30","author":"Chen","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/bjd.16779-BIB0014|bjd16779-cit-0014","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamaoto.2013.4773","article-title":"Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas","volume":"139","author":"Thaivalappil","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1111\/bjd.16779-BIB0015|bjd16779-cit-0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bjps.2010.08.039","article-title":"Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution","volume":"64","author":"Itinteang","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1111\/bjd.16779-BIB0016|bjd16779-cit-0016","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and use of propranolol for infantile hemangioma: report of a consensus conference","volume":"131","author":"Drolet","year":"2013","journal-title":"Pediatrics"},{"key":"10.1111\/bjd.16779-BIB0017|bjd16779-cit-0017","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00431-015-2570-0","article-title":"Treatment of infantile haemangiomas: recommendations of a European expert group","volume":"174","author":"Hoeger","year":"2015","journal-title":"Eur J Ped"},{"key":"10.1111\/bjd.16779-BIB0018|bjd16779-cit-0018","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ypmed.2010.08.005","article-title":"AGREE II: advancing guideline development, reporting, and evaluation in health care","volume":"51","author":"Brouwers","year":"2010","journal-title":"Prev Med"},{"key":"10.1111\/bjd.16779-BIB0019|bjd16779-cit-0019","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jpeds.2007.04.055","article-title":"Multicenter prospective study of ulcerated hemangiomas","volume":"151","author":"Chamlin","year":"2007","journal-title":"J Pediatr"},{"key":"10.1111\/bjd.16779-BIB0020|bjd16779-cit-0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaad.2015.10.021","article-title":"Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH)","volume":"74","author":"Boos","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16779-BIB0021|bjd16779-cit-0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0045-9380(96)80023-5","article-title":"Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes","volume":"26","author":"Esterly","year":"1996","journal-title":"Curr Probl Pediatr"},{"key":"10.1111\/bjd.16779-BIB0022|bjd16779-cit-0022","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0002-9394(14)78109-7","article-title":"Ophthalmic sequelae of infantile hemangiomas of the eyelids and orbit","volume":"85","author":"Stigmar","year":"1978","journal-title":"Am J Ophtalmol"},{"key":"10.1111\/bjd.16779-BIB0023|bjd16779-cit-0023","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/pde.12928","article-title":"Infantile hemangiomas of the lip: patterns, outcomes, and implications","volume":"33","author":"Yanes","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/bjd.16779-BIB0024|bjd16779-cit-0024","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jamadermatol.2016.2905","article-title":"Risk factors for degree and type of sequelae after involution of untreated hemangiomas of infancy","volume":"152","author":"Baselga","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.16779-BIB0025|bjd16779-cit-0025","volume-title":"Handbook of Emergency Cardiovascular Care for Healthcare Providers","author":"Heart and Stroke Foundation of Canada","year":"2015"},{"key":"10.1111\/bjd.16779-BIB0026|bjd16779-cit-0026","unstructured":"Propranolol Pediatric drug information https:\/\/www.uptodate.com\/contents\/propranolol-drug-information"},{"key":"10.1111\/bjd.16779-BIB0027|bjd16779-cit-0027","unstructured":"Paediatric Formulary Committe BNF for children https:\/\/www.medicinescomplete.com\/mc\/bnfc\/current\/PHP944-propranolol-hydrochloride.htm"},{"key":"10.1111\/bjd.16779-BIB0028|bjd16779-cit-0028","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1525-1470.2012.01879.x","article-title":"Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants","volume":"30","author":"Metry","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/bjd.16779-BIB0029|bjd16779-cit-0029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpeds.2016.07.054","article-title":"PHACE syndrome: consensus-derived diagnosis and care recommendations","volume":"178","author":"Garzon","year":"2016","journal-title":"J Pediatr"},{"key":"10.1111\/bjd.16779-BIB0030|bjd16779-cit-0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jpc.12720","article-title":"Low-dose propranolol regimen for infantile haemangioma","volume":"51","author":"Tan","year":"2014","journal-title":"J Paediatr Child Health"},{"key":"10.1111\/bjd.16779-BIB0031|bjd16779-cit-0031","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/bjd.15317","article-title":"Atenolol treatment for infantile haemangioma","volume":"176","author":"Tasani","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16779-BIB0032|bjd16779-cit-0032","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2340\/00015555-2681","article-title":"The role of topical timolol in the treatment of infantile hemangiomas: a systematic review and meta-analysis","volume":"97","author":"Khan","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.16779-BIB0033|bjd16779-cit-0033","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bjd.13379","article-title":"Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas","volume":"172","author":"Langley","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16779-BIB0034|bjd16779-cit-0034","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaad.2017.01.025","article-title":"Propranolol treatment of infantile hemangioma is not associated with psychological problems at 7\u00a0years of age","volume":"77","author":"Moyakine","year":"2017","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16779","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16779\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:41:40Z","timestamp":1676382100000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/179\/3\/582\/6732447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16779","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}